BlackRock Institutional Trust’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$4.5M Buy
968,608
+14,656
+2% +$68.2K ﹤0.01% 2764
2016
Q3
$7.38M Buy
953,952
+54,213
+6% +$420K ﹤0.01% 2522
2016
Q2
$5.45M Sell
899,739
-26,968
-3% -$163K ﹤0.01% 2631
2016
Q1
$7.9M Buy
926,707
+29,898
+3% +$255K ﹤0.01% 2414
2015
Q4
$10.7M Buy
896,809
+28,713
+3% +$343K ﹤0.01% 2279
2015
Q3
$8.75M Buy
868,096
+124,990
+17% +$1.26M ﹤0.01% 2377
2015
Q2
$12.3M Buy
743,106
+9,504
+1% +$158K ﹤0.01% 2265
2015
Q1
$11.4M Buy
733,602
+219,161
+43% +$3.39M ﹤0.01% 2317
2014
Q4
$8.15M Buy
514,441
+288,699
+128% +$4.57M ﹤0.01% 2477
2014
Q3
$2.41M Sell
225,742
-18,453
-8% -$197K ﹤0.01% 2990
2014
Q2
$2.29M Buy
244,195
+76,612
+46% +$719K ﹤0.01% 3122
2014
Q1
$1.16M Buy
167,583
+30,320
+22% +$209K ﹤0.01% 3364
2013
Q4
$535K Sell
137,263
-25,969
-16% -$101K ﹤0.01% 3555
2013
Q3
$823K Buy
163,232
+38,038
+30% +$192K ﹤0.01% 3409
2013
Q2
$800K Buy
+125,194
New +$800K ﹤0.01% 3389